Photobiomodulation therapy in management of cancer therapy-induced side effects: WALT position paper 2022.

Saved in:
Bibliographic Details
Title: Photobiomodulation therapy in management of cancer therapy-induced side effects: WALT position paper 2022.
Authors: Robijns J; UHasselt, Faculty of Medicine and Life Sciences, Diepenbeek, Belgium., Nair RG; Oral Medicine, Oral Pathology and Oral Oncology, Griffith University, Department of Haematology and Oncology, Gold Coast University Hospital, Gold Coast, QL, Australia., Lodewijckx J; UHasselt, Faculty of Medicine and Life Sciences, Diepenbeek, Belgium., Arany P; School of Dental Medicine, Oral Biology and Biomedical Engineering, University at Buffalo, Buffalo, NY, United States., Barasch A; Harvard School of Dental Medicine, Division of Oral Medicine and Dentistry, Boston, MA, United States., Bjordal JM; Physiotherapy Research Group, IGS, University of Bergen, Bergen, Norway., Bossi P; Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Brescia, Italy., Chilles A; Radiotherapy Department, Institut Curie, Paris, France., Corby PM; New York University College of Dentistry, Bluestone Center for Clinical Research, New York, NY, United States., Epstein JB; City of Hope Duarte, CA and Cedars-Sinai Health System, Los Angeles, CA, United States., Elad S; Eastman Institute for Oral Health, University of Rochester Medical Center, Rochester, NY, United States., Fekrazad R; Department of Periodontology, Dental Faculty - Radiation Sciences Research Center, Laser Research Center in Medical Sciences, AJA University of Medical Sciences, Tehran, Iran., Fregnani ER; Oral Medicine Department, Hospital Sírio-Libanês, São Paulo, Brazil., Genot MT; Laser Therapy Unit, Institut Jules Bordet, Centre des Tumeurs de l'Université Libre de Bruxelles, Brussels, Belgium., Ibarra AMC; Postgraduate Program on Biophotonics Applied to Health Sciences, Nove de Julho University, São Paulo, Brazil., Hamblin MR; Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States., Heiskanen V; Oral and Maxillofacial Diseases, University of Helsinki, Helsinki, Finland., Hu K; Department of Radiation Oncology, NYU Langone Health, New York, NY, United States., Klastersky J; Medical Oncology, Institut Jules Bordet, Brussels, Belgium., Lalla R; Section of Oral Medicine, University of Connecticut School of Dental Medicine, Farmington, CT, United States., Latifian S; Department of Medicine, Institut Jules Bordet, Universiteí Libre de Bruxelles, Brussels, Belgium., Maiya A; Manipal College of Health Professions, MAHE, Manipal, India., Mebis J; UHasselt, Faculty of Medicine and Life Sciences, Diepenbeek, Belgium., Migliorati CA; Department of Oral and Maxillofacial Diagnostic Sciences, University of Florida College of Dentistry, Gainesville, Florida, United States., Milstein DMJ; Oral and Maxillofacial Surgery, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands., Murphy B; Department of Oncology, Vanderbilt University Medical Center, Nashville, TN, United States., Raber-Durlacher JE; Department of Oral and Maxillofacial Surgery, Amsterdam UMC, University of Amsterdam, Department of Oral Medicine, Academic Centre for Dentistry Amsterdam, University of Amsterdam and VU University, Amsterdam, Netherlands., Roseboom HJ; Department of Oral and Maxillofacial Surgery, Amsterdam UMC, University of Amsterdam, Department of Oral Medicine, Academic Centre for Dentistry Amsterdam, University of Amsterdam and VU University, Amsterdam, Netherlands., Sonis S; Division of Oral Medicine and Dentistry, Brigham and Women's Hospital; Department of Oral Medicine, Infection and Immunity, Harvard School of Dental Medicine; Division of Oral Medicine and Dentistry, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Boston, MA, United States., Treister N; Division of Oral Medicine and Dentistry, Brigham and Women's Hospital; Department of Oral Medicine, Infection and Immunity, Harvard School of Dental Medicine; Division of Oral Medicine and Dentistry, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Boston, MA, United States., Zadik Y; Department of Military Medicine, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel, and Department of Oral Medicine, Sedation and Maxillofacial Imaging, Hebrew University-Hadassah School of Dental Medicine, Jerusalem, Israel., Bensadoun RJ; Department of Radiation Oncology, Centre de Haute Energie, Nice, France.
Source: Frontiers in oncology [Front Oncol] 2022 Aug 30; Vol. 12, pp. 927685. Date of Electronic Publication: 2022 Aug 30 (Print Publication: 2022).
Publication Type: Systematic Review; Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2234-943X
DOI:10.3389/fonc.2022.927685